Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Diagnostics & Research


Interviews

Canada’s top edible cannabis producer eyes further growth

Medicus Pharma advances cancer treatment towards phase II trial

Emerging opportunity in a growing, high-value dermatological market

Pharmaceutical company treats bladder cancer with new tech

Press Releases

Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From Operations

  Apr 25, 2024

AGL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds agilon health, inc. Investors to...

  Apr 26, 2024

Zoetis Inc. (ZTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek...

  Apr 26, 2024

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Catalent, Inc. (CTLT) Investigation

  Apr 26, 2024

TUESDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc....

  Apr 26, 2024

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic...

  Apr 26, 2024

Premier, Inc. Declares Quarterly Cash Dividend

  Apr 26, 2024

Nova Leap Health Corp. Announces Execution of Definitive Agreement

  Apr 26, 2024

Citius Pharmaceuticals Announces $15 Million Registered Direct Offering

  Apr 26, 2024

The Cannabist Company and Airo Brands Continue Successful Partnership with Expansion into Pennsyl...

  Apr 26, 2024

SNDL to Announce First Quarter 2024 Financial Results on May 9, 2024

  Apr 26, 2024

Mitesco Expands Advisory Board With Senior Technology, Infrastructure Execs

  Apr 26, 2024

New Report: Employers Play Critical Role in Curbing Today's Youth Mental Health Crisis

  Apr 26, 2024

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolu...

  Apr 26, 2024

Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management

  Apr 26, 2024

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical...

  Apr 25, 2024

Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024

  Apr 26, 2024

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

  Apr 26, 2024

Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024

  Apr 26, 2024

Nuwellis Announces Pricing of $2.7 Million Public Offering

  Apr 26, 2024

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024...

  Apr 26, 2024

Biodexa Enters Into Exclusive License to eRapa(TM), a Phase 3 Ready Asset for the Treatment of...

  Apr 26, 2024

Exagen Inc. Announces Changes to the Board of Directors

  Apr 26, 2024

Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to...

  Apr 26, 2024

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

  Apr 26, 2024

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on...

  Apr 26, 2024

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in...

  Apr 26, 2024

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp....

  Apr 26, 2024

Align Technology Announces $150 Million Open Market Repurchase

  Apr 26, 2024

GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action...

  Apr 26, 2024

AbbVie Reports First-Quarter 2024 Financial Results

  Apr 26, 2024

AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY

  Apr 26, 2024

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with...

  Apr 26, 2024

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a...

  Apr 26, 2024

BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report

  Apr 26, 2024

Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium

  Apr 26, 2024

Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by...

  Apr 26, 2024

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics,...

  Apr 26, 2024

An Investigation Has Commenced on Behalf of Teladoc Health, Inc. Shareholders. Contact Levi &...

  Apr 26, 2024

Medtronic receives FDA approval for Inceptiv(TM) closed-loop spinal cord stimulator

  Apr 26, 2024

Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars

  Apr 26, 2024

Lost Money on bluebird bio, Inc.(BLUE)? Join Class Action Suit Seeking Recovery - Contact Levi &...

  Apr 26, 2024

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic...

  Apr 26, 2024

Cutera to Announce First Quarter Results on May 9, 2024

  Apr 26, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar...

  Apr 26, 2024

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

  Apr 26, 2024

Senzime Signs its First Group Purchasing Organization (GPO) Contract with Major US Hospital...

  Apr 26, 2024

Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro,...

  Apr 26, 2024

BLUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds bluebird bio, Inc. Investors to...

  Apr 26, 2024

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 11, 2024 in QuidelOrth...

  Apr 26, 2024

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and...

  Apr 26, 2024

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities

Companies of Interest

Gemina Laboratories Ltd.